What's new
Information from the previous month appears monthly in the newsletter “What'sNew” (link to registration page).
For the RSS feed with daily notifications of updates, use the link: RSS feed for “What'sNew”.
Search narrowed by
11/11/2024
Dem Bundesamt für Sicherheit im Gesundheitswesen wurde von der ECDC (European Centre for Disease Prevention and Control) mitgeteilt, dass in Bulgarien, zusätzlich zu den bereits bekannt gegebenen Regionen, in Kardzhali, bestätigte humane WNV-Infektionen verzeichnet wurden
Referenced at:
11/11/2024
Dem Bundesamt für Sicherheit im Gesundheitswesen wurde von der ECDC (European Centre for Disease Prevention and Control) mitgeteilt, dass in der Türkei, zusätzlich zu den bereits bekannt gegebenen Regionen, in Tekirdağ, bestätigte humane WNV-Infektionen verzeichnet wurden.
Referenced at:
Fluoroquinolones (for systemic and inhalation use) New
PSUFU
|
08/11/2024
Further information is available on the hma-Website.
5_Fluorouracil (iv use) New
PSUR-outcome
|
08/11/2024
Further information and amendments to the product information in all EU languages are available on the EMA website.
Amantadine New
PSUR-outcome
|
30/10/2024
Further information and amendments to the product information in all EU languages are available on the EMA website.
valproic acid and derivates New
PSUR-outcome
|
29/10/2024
Further information and amendments to the product information in all EU languages are available on the EMA website.
Macrogol 3350- combinations (oral use) New
PSUR-outcome
|
29/10/2024
Further information and amendments to the product information in all EU languages are available on the EMA website.
Allopurinol New
PSUR-outcome
|
29/10/2024
Further information and amendments to the product information in all EU languages are available on the EMA website.
Medroxyprogesterone acetate (MPA) New
PRAC signal recommendation
|
08/10/2024
Risk for Meningioma. Further information and amendments to the product information can be found on the EMA website.
14/11/2024
Referenced at: